Session Details

Clinical Trial Update 1
28 Aug 14:00 - 15:30 Miscellaneous Clinical Trial Update Dali - The Hub
Chairpersons: Ian Maklim GRAHAM (Wicklow, Ireland)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:00 Increased all-cause mortality with intensive blood-pressure control in patients with a baseline systolic blood pressure of >=160 mmHg and a Lower Framingham risk score: a cautionary note from SPRINTTzung-Dau WANG (Taipei City, Taiwan ROC)
14:15 Systolic Blood Pressure Variability and Major Adverse Outcomes in Patients with Atrial Fibrillation: the AFFIRM StudyMarco PROIETTI (Birmingham, United Kingdom)
14:30 Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes TrialRobert Patrick GIUGLIANO (Boston, United States of America)
14:45 The long-term efficacy and safety of short dual antiplatelet therapy Masato NAKAMURA (Tokyo, Japan)
15:00 Mechanisms for the benefit of spironolactone in resistant hypertension in the PATHWAY-2 studyBryan WILLIAMS (London, United Kingdom)
15:15 Aldosterone Lethal Effects Blocked in Acute Myocardial Infarction Treated With or Without Repercussion to Improve Outcome and Survival at Six Months Follow-upFarzin BEYGUI (Caen, France)

Who we are

What we do

How we work

More ESC